Ubiquitin-Modifying Enzymes as Cell-Fate Regulators in Intestinal Inflammation

Area of Science:

• Gastroenterology
• Molecular Biology
• Immunology

Background:

• Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is a chronic gastrointestinal inflammatory condition.
• Intestinal homeostasis depends on precise cell fate regulation in the epithelium and immune system.
• Ubiquitin-modifying enzymes (UMEs) are key regulators of protein stability, activity, and localization, influencing these cellular processes.

Purpose of the Study:

• To review the critical roles of UMEs in cell fate determination within the intestine.
• To examine the impact of UMEs on intestinal barrier function and immune responses.
• To discuss the involvement of UMEs in IBD pathogenesis and their potential as therapeutic targets.

Main Methods:

• Systematic review of current literature on UMEs and intestinal homeostasis.
• Analysis of the role of UMEs in regulating intestinal epithelial and immune cell fate.
• Exploration of UME dysregulation in IBD and potential therapeutic strategies.

Main Results:

• UMEs are essential for controlling cell fate decisions impacting intestinal barrier integrity and immune responses.
• Specific UMEs are pathologically dysregulated in IBD, indicating their involvement in disease development.
• UMEs show promise as diagnostic biomarkers and therapeutic targets for IBD management.

Conclusions:

• UMEs play a fundamental role in ubiquitin-mediated regulation of intestinal cell fate.
• Targeting UMEs offers novel therapeutic avenues for managing IBD and preventing colitis-associated cancer (CAC).
• Emerging strategies like small-molecule inhibitors and PROTAC technology present new clinical applications for UME-targeted therapies.